Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2021 | Story Dikgapane Makhetha | Photo Supplied
Bishop Billyboy Ramahlele (Director: Community Engagement), Napo Masheane (lead actress), and Troy Myeni (Director)

A short fiction film that was shot in Botshabelo and on the Bloemfontein Campus of the UFS, has once again shown the endless possibilities of engaged scholarship in the creative arts.

For this film project, engaged scholarship meant working with graduates / current students from the UFS on projects with a relevant and impactful theme for the broader community. The project was aimed at giving current or past students the opportunity to gain experience or share experience and to transfer skills in the area of filmmaking. 

The short fiction film, Leshano (The Lie), was directed by Mpendulo ‘Troy’ Myeni, a graduate of the UFS Film Programme, who also won an award at the Pan African Film Festival in the US for another of his short films.  Troy was also one of the three co-producers, along with Anton Fisher (a former employee of the UFS), who wrote the script, and Moeketsi Mphunye, a young filmmaker from Botshabelo.
Another notable UFS graduate who was central to the production, is Mbuyiselo Nqodi. He graduated with a BA in Drama and Theatre Arts and has since gone on to make a huge contribution to the performing arts in the Free State and South Africa. Mbuyiselo was the first assistant director of Leshano (The Lie) and had the unenviable job of keeping everything moving on set.  Other members of the production registered at the UFS, but never completed their studies. 

Bishop Billyboy Ramahlele, Director of Community Engagement at the UFS, said he was proud that the UFS could be part of this filmmaking project by making offices available as locations for the film and through the participation of distinguished graduates in key positions of the production.

“The UFS has much to offer young people as students, but also as graduates who seek to advance in their chosen careers. Through community engagement, these young people, whether students or graduates, can be inspired by working with professionals in various fields and gaining hands-on experience. They can then plough back into the community and the UFS.”

“This is the virtuous cycle of community engagement at a university. Students gain knowledge, then they gain inspiration and experience, and plough back into the UFS and broader community, instilling hope for future generations,” Bishop Ramahlele said. 

He added that the UFS would be mentioned in the credits of the film and in publicity and marketing of the film, profiling its reputation as a centre of creative excellence.

Leshano (The Lie) was filmed in Sesotho, with English subtitles, and deals with the important issue of corruption. The lead role is played by the acclaimed Napo Masheane who grew up in Qwaqwa, supported by well-known Free State actors Maria de Koker, Seipati Mpotoane, Ntsiki Ndzume, Vincent Tsoametsi, Pesa Pheko, and Shayne Nketsi. 

Several young, aspiring filmmakers from across the Free State were recruited for the project. It was their first time on the set of a film production, whether as make-up artists, behind the scenes photographers, unit production managers, wardrobe assistants, or location scouts. 

With a strong line-up of women in the lead roles, the film will be released later in August during Women’s Month. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept